Dr. Steven D Martin, M.D. Emergency Medicine - Emergency Medical Services Medicare: Medicare Enrolled Practice Location: 145 W. Us Hwy 54, Camdenton, MO 65020 Phone: 573-873-7138 |
News Archive
GlaxoSmithKline and XenoPort, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review GSK's response to FDA's Complete Response letter for Horizant (gabapentin enacarbil) Extended-Release Tablets. Horizant is under review for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
A team of researchers at the Institute of Infectious Diseases (IFIK) at the University of Bern and the Institute of Virology and Immunology (IVI) has utilized a unique collection of advanced cell culture models of cells lining the airways from various domesticated and wildlife animals. This way, the team can determine which animals are susceptible to SARS-CoV-2 infection.
MSD (Merck & Co., Inc., Kenilworth, New Jersey, USA) today announced that on 22 June the European Commission approved SIMPONI (golimumab) for the treatment of adult patients with severe, active non-radiographic axial spondyloarthritis (nr-axial SpA).
A new study by the Centre for Addiction and Mental Health showed positive changes in attitudes and a reduction in patient agitation after implementing a fully tobacco-free environment at Canada's largest mental health and addiction teaching hospital.
› Verified 6 days ago